Sanofi, a global leader in research and development services, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has since established itself as a key player in the pharmaceutical industry, focusing on innovative solutions in healthcare.
Specialising in prescription medicines, vaccines, and consumer healthcare products, Sanofi is renowned for its commitment to addressing unmet medical needs. Its core offerings include treatments for diabetes, cardiovascular diseases, and rare diseases, distinguished by their cutting-edge research and development processes. With a strong market position, Sanofi has achieved significant milestones, including advancements in biologics and immunotherapy, solidifying its reputation as a pioneer in the pharmaceutical landscape.
+71 vs industry average
Sanofi’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sanofi?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Sanofi's reported carbon emissions
Sanofi, a research and development services company headquartered in France, has made significant commitments to address its carbon emissions and combat climate change. **Carbon Emissions Overview:** For the year 2025, Sanofi reported a total of approximately 4.45 billion kg CO2e. This figure comprises: * **Scope 1 emissions:** Approximately 235 million kg CO2e. * **Scope 2 emissions:** Approximately 70 million kg CO2e (market-based). * **Scope 3 emissions:** Approximately 3.44 billion kg CO2e, with the largest contributions coming from purchased goods and services (approximately 2.39 billion kg CO2e). In 2024, Sanofi's total emissions were approximately 4.66 billion kg CO2e, with Scope 1 emissions at roughly 299 million kg CO2e and Scope 2 (market-based) at approximately 76 million kg CO2e. Scope 3 emissions for 2024 were approximately 3.50 billion kg CO2e, heavily influenced by purchased goods and services (approximately 2.66 billion kg CO2e). Previous years' data also shows significant emissions, with 2023 reporting approximately 4.80 billion kg CO2e in total emissions, Scope 1 at approximately 288 million kg CO2e, and Scope 2 (market-based) at around 83 million kg CO2e. Scope 3 emissions for 2023 were approximately 3.79 billion kg CO2e, with purchased goods and services accounting for roughly 2.69 billion kg CO2e. **Climate Commitments and Reduction Targets:** Sanofi has established ambitious targets aligned with global climate goals: * **Net-Zero Commitment:** Sanofi is committed to reaching net-zero greenhouse gas (GHG) emissions across its value chain by 2045, with an intermediate trajectory towards carbon neutrality by 2030. This overall net-zero target has been validated by the Science Based Targets initiative (SBTi). * **Scope 1 & 2 Emissions Reduction:** * Sanofi aims to reduce its absolute Scope 1 and 2 GHG emissions by 55% by 2030, compared to a 2019 baseline. This target has been validated by the SBTi as consistent with limiting global warming to 1.5°C. * An earlier target was to reduce absolute Scope 1 and 2 GHG emissions by 30% by 2025 from a 2019 base year. * **Scope 3 Emissions Reduction:** Sanofi has committed to reducing its absolute Scope 3 GHG emissions by 30% by 2030 from a 2019 base year. This reduction specifically targets categories including purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting. * **Renewable Electricity:** Sanofi aims to increase its annual sourcing of renewable electricity from 11% in 2019 to 80% by 2025 and 100% by 2030. Sanofi's commitments are underpinned by comprehensive reporting of its Scope 1, 2, and 3 emissions, demonstrating a commitment to transparency and environmental stewardship in the research and development services sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sanofi’s Climate Goals (2030 & 2050)
5 goals2030
30% reduction in scope 3 total
• on climate change mitigation (i) reducing our greenhouse gas (GHG) emissions (Scopes 1 & 2) by 55% and our Scope 3 emissions by 30% by 20…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 5 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
12 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Sanofi’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project